Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
Akebia Therapeutics (AKBA) Stock Price & Analysis
863 Followers
AKBA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.24 - $1.84
Previous Close$1.14
Volume1.35M
Average Volume (3M)1.74M
Market Cap
$214.68M
Enterprise Value$215.07M
Total Cash (Recent Filing)$53.57M
Total Debt (Recent Filing)$53.97M
Price to Earnings (P/E)-2.1
Beta0.98
Next Earnings
Nov 09, 2023EPS Estimate
-$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding188,313,807
10 Day Avg. Volume1,051,196
30 Day Avg. Volume1,740,938
Standard Deviation0.31
R-Squared0.02
Alpha0.00878
Financial Highlights & Ratios
Price to Book (P/B)-1.53
Price to Sales (P/S)5.13
Price to Cash Flow (P/CF)14.70
P/FCF Ratio14.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit0.74
Enterprise Value/Ebitda-87.64
Forecast
1Y Price Target
$3.88Price Target Upside269.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Akebia Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AKBA FAQ
What was Akebia Therapeutics’s price range in the past 12 months?
Akebia Therapeutics lowest stock price was $0.24 and its highest was $1.84 in the past 12 months.
What is Akebia Therapeutics’s market cap?
Currently, no data Available
When is Akebia Therapeutics’s upcoming earnings report date?
Akebia Therapeutics’s upcoming earnings report date is Nov 09, 2023 which is in 37 days.
How were Akebia Therapeutics’s earnings last quarter?
Akebia Therapeutics released its earnings results on Aug 25, 2023. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of -$0.025 by -$0.035.
Is Akebia Therapeutics overvalued?
According to Wall Street analysts Akebia Therapeutics’s price is currently Undervalued.
Does Akebia Therapeutics pay dividends?
Akebia Therapeutics does not currently pay dividends.
What is Akebia Therapeutics’s EPS estimate?
Akebia Therapeutics’s EPS estimate is -$0.09.
How many shares outstanding does Akebia Therapeutics have?
Akebia Therapeutics has 188,313,810 shares outstanding.
What happened to Akebia Therapeutics’s price movement after its last earnings report?
Akebia Therapeutics reported an EPS of -$0.06 in its last earnings report, missing expectations of -$0.025. Following the earnings report the stock price went down -8%.
Which hedge fund is a major shareholder of Akebia Therapeutics?
Among the largest hedge funds holding Akebia Therapeutics’s share is Graham Capital Management, L.P.. It holds Akebia Therapeutics’s shares valued at 24K.
---
Akebia Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.88 (269.52% Upside)
$3.88 (269.52% Upside)
Blogger Sentiment
Bullish
AKBA Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 26.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days >0.1%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
263.92%
12-Months-Change
Fundamentals
Return on Equity
-554.87%
Trailing 12-Months
Asset Growth
-51.38%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Akebia Therapeutics
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding AKBA
Vanguard Total Stock Market ETF
$6.43M
Up to five ETFs with an Outperform Smart Score that hold AKBA. The ETFs are listed according to market value of AKBA within the ETF
---